AT277475B - Verfahren zur herstellung von neuen n6-aralkyl-adenosinderivaten - Google Patents

Verfahren zur herstellung von neuen n6-aralkyl-adenosinderivaten

Info

Publication number
AT277475B
AT277475B AT06861/68A AT686168A AT277475B AT 277475 B AT277475 B AT 277475B AT 06861/68 A AT06861/68 A AT 06861/68A AT 686168 A AT686168 A AT 686168A AT 277475 B AT277475 B AT 277475B
Authority
AT
Austria
Prior art keywords
aralkyl
new
production
adenosine derivatives
adenosine
Prior art date
Application number
AT06861/68A
Other languages
English (en)
Original Assignee
Boehringer Mannheim Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Mannheim Gmbh filed Critical Boehringer Mannheim Gmbh
Application granted granted Critical
Publication of AT277475B publication Critical patent/AT277475B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT06861/68A 1966-12-09 1967-12-07 Verfahren zur herstellung von neuen n6-aralkyl-adenosinderivaten AT277475B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DEB0090219 1966-12-09
DEB0093416 1967-07-11

Publications (1)

Publication Number Publication Date
AT277475B true AT277475B (de) 1969-12-29

Family

ID=25968244

Family Applications (2)

Application Number Title Priority Date Filing Date
AT1110667A AT276640B (de) 1966-12-09 1967-12-07 Verfahren zur Herstellung von neuen N<6>-Aralkyl-adenosin-derivaten
AT06861/68A AT277475B (de) 1966-12-09 1967-12-07 Verfahren zur herstellung von neuen n6-aralkyl-adenosinderivaten

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT1110667A AT276640B (de) 1966-12-09 1967-12-07 Verfahren zur Herstellung von neuen N<6>-Aralkyl-adenosin-derivaten

Country Status (8)

Country Link
US (1) US3506643A (de)
AT (2) AT276640B (de)
CH (2) CH491119A (de)
FI (1) FI49302C (de)
FR (2) FR1550512A (de)
GB (1) GB1145789A (de)
NL (1) NL130339C (de)
SE (1) SE323383B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2007273A1 (de) * 1970-02-18 1971-08-26 Boehnnger Mannheim GmbH, 6800 Mann heim Waldhof N(6) Aralkyl adenosin Derivate und Verfahren zur Herstellung derselben
DE2244328A1 (de) * 1972-09-09 1974-03-21 Boehringer Mannheim Gmbh Neue n(6)-disubstituierte adenosinderivate und verfahren zur herstellung derselben
US4514405A (en) * 1981-09-17 1985-04-30 Merck Patent Gesellschaft Mit Beschrankter Haftung Use of adenosine derivatives as anticonvulsants
US5284834A (en) * 1985-03-29 1994-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Adenosine functionalized congeners as cardiovascular treating agents for animals and methods for using same
JPS63208525A (ja) * 1987-02-25 1988-08-30 Kikkoman Corp 心不全治療剤
WO1994002497A1 (en) * 1992-07-15 1994-02-03 The United States Of America, Represented By The Secretary, Department Of Health And Human Services Sulfo-derivatives of adenosine
IL150594A0 (en) * 2000-01-07 2003-02-12 Ustav Ex Botan Adademie Ved Ce Purine derivatives, process for their preparation and use
CZ294538B6 (cs) * 2002-12-30 2005-01-12 Ústav Experimentální Botaniky Akademie Vědčeské Re Substituční deriváty N6-benzyladenosinu, způsob jejich přípravy, jejich použití pro přípravu léčiv, kosmetických přípravků a růstových regulátorů, farmaceutické přípravky, kosmetické přípravky a růstové regulátory tyto sloučeniny obsahující
US20070161582A1 (en) * 2003-08-08 2007-07-12 Dusan Mijikovic Pharmaceutical compositions and methods for metabolic modulation
KR101763656B1 (ko) 2009-06-29 2017-08-01 인사이트 홀딩스 코포레이션 Ｐｉ3ｋ 저해물질로서의 피리미디논
TW201130842A (en) * 2009-12-18 2011-09-16 Incyte Corp Substituted fused aryl and heteroaryl derivatives as PI3K inhibitors
US8759359B2 (en) * 2009-12-18 2014-06-24 Incyte Corporation Substituted heteroaryl fused derivatives as PI3K inhibitors
EP2558463A1 (de) 2010-04-14 2013-02-20 Incyte Corporation Kondensierte derivate als i3-hemmer
WO2011163195A1 (en) 2010-06-21 2011-12-29 Incyte Corporation Fused pyrrole derivatives as pi3k inhibitors
EP3660016A1 (de) 2010-12-20 2020-06-03 Incyte Holdings Corporation N-(1-(substituierte phenyl)ethyl)-9h-purin-6-amine als pi3k-hemmer
US9108984B2 (en) 2011-03-14 2015-08-18 Incyte Corporation Substituted diamino-pyrimidine and diamino-pyridine derivatives as PI3K inhibitors
WO2012135009A1 (en) 2011-03-25 2012-10-04 Incyte Corporation Pyrimidine-4,6-diamine derivatives as pi3k inhibitors
PT3513793T (pt) 2011-09-02 2021-05-10 Incyte Holdings Corp Heterociclilaminas como inibidores de pi3k
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
WO2015191677A1 (en) 2014-06-11 2015-12-17 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
SG10201907576SA (en) 2015-02-27 2019-09-27 Incyte Corp Salts of pi3k inhibitor and processes for their preparation
US9732097B2 (en) 2015-05-11 2017-08-15 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
US9988401B2 (en) 2015-05-11 2018-06-05 Incyte Corporation Crystalline forms of a PI3K inhibitor
SG11202011680YA (en) 2018-06-01 2020-12-30 Incyte Corp Dosing regimen for the treatment of pi3k related disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3014900A (en) * 1959-01-26 1961-12-26 Upjohn Co Process for the preparation of ketosidopurines

Also Published As

Publication number Publication date
CH509326A (de) 1971-06-30
CH491119A (de) 1970-05-31
GB1145789A (en) 1969-03-19
FR7285M (de) 1969-09-22
AT276640B (de) 1969-11-25
NL6716737A (de) 1968-06-10
FR1550512A (de) 1968-12-20
SE323383B (de) 1970-05-04
US3506643A (en) 1970-04-14
FI49302B (de) 1975-01-31
NL130339C (de) 1970-12-15
FI49302C (fi) 1975-05-12

Similar Documents

Publication Publication Date Title
CH500952A (de) Verfahren zur Herstellung von neuen Amidinoharnstoffen
AT270866B (de) Verfahren zur Herstellung von neuen Penicillinen
AT277475B (de) Verfahren zur herstellung von neuen n6-aralkyl-adenosinderivaten
AT272529B (de) Verfahren zur Herstellung von neuen Adenosin-Derivaten
CH474522A (de) Verfahren zur Herstellung von neuen Imidazolderivaten
AT296324B (de) Verfahren zur Herstellung von neuen Xanthenderivaten
AT269855B (de) Verfahren zur Herstellung von neuen 5-Nitrofuran- bzw. 5-Nitrothiopen-Derivaten
CH438319A (de) Verfahren zur Herstellung von neuen Azepinderivaten
CH494767A (de) Verfahren zur Herstellung von neuen Pteridinen
AT301766B (de) Verfahren zur Herstellung von neuen 9α-unsubstituierten 11β-Chlor-19-nor-steroiden
AT282059B (de) Verfahren zur Herstellung von neuen Penicillinen
CH493547A (de) Verfahren zur Herstellung von neuen Pteridinen
AT276421B (de) Verfahren zur Herstellung von neuen 4-Alkoxy-propylenharnstoff-bzw. -thioharnstoffderivaten
AT281282B (de) Verfahren zur Herstellung von neuen Penicillinen
AT322569B (de) Verfahren zur herstellung von neuen thiobenzoylaminoalkylbenzolsulfonylharnstoffen
AT283349B (de) Verfahren zur herstellung von neuen 1-acyl-3-indolylcarbonsaeurederivaten
AT272363B (de) Verfahren zur Herstellung von neuen Thiosemicarbazonen
CH475973A (de) Verfahren zur Herstellung von neuen Polyepoxiden
AT279813B (de) Verfahren zur Herstellung von neuen 3β-Formoxy-15α-halogen-14β-hydroxy-5β-card-20(22)-enoliden
AT269383B (de) Verfahren zur Herstellung von neuen Steroido-oxazolinen
AT271757B (de) Verfahren zur Herstellung von neuen Nitroöstratrienen
AT266831B (de) Verfahren zur Herstellung von neuen Isoxazolderivaten
CH493529A (de) Verfahren zur Herstellung von neuen Chinazolinonderivaten
CH489519A (de) Verfahren zur Herstellung von neuen 5-Nitrofuranderivaten
CH489524A (de) Verfahren zur Herstellung von neuen 5-Nitrofuranderivaten